NEWA

Overview

NEWA is the only home-use radiofrequency (RF) device with an FDA De Novo clearance for wrinkle reduction (DEN150005). It’s manufactured by EndyMed Medical, an Israeli aesthetic-technology company whose clinical 3DEEP RF platform is used in dermatology offices worldwide. The home version uses the same six-generator RF architecture, scaled down for consumer use and constrained by a temperature-sensor-enforced safety envelope.

The 2026 anti-aging device landscape sits at the inflection where regulatory differentiation matters more than ever — most home-RF devices market under “FDA-registered” (an administrative listing) without clearance for any therapeutic claim. NEWA’s actual clearance is the structural moat. The buyer’s question isn’t whether NEWA’s claims are real; it’s whether 20-minute sessions three times a week fit your life.

What We Measured

Note: This review is based on the FDA De Novo clearance file (DEN150005), the manufacturer’s published clinical study, and user reports. Hands-on testing of the device’s RF output, temperature sensor behavior, and gel consumption rate is pending.

Clinical evidence

EndyMed’s home-use RF clinical study reported visible wrinkle improvement in 100% of participants over the protocol period. The study underpinned the De Novo clearance and is the strongest published clinical evidence for any home-use RF device. Study design specifics (sample size, sham-controlled status, blinding) should be cross-checked against the De Novo summary on accessdata.fda.gov before using the “100% improvement” headline as an absolute.

RF technology

3DEEP RF uses six generators delivering RF energy across multiple penetration depths — a smaller-scale version of the EndyMed clinical platform used in dermatology offices. Temperature sensors monitor skin contact temperature in real time and modulate output to keep the treatment within a safety envelope. The home device is rated for the manufacturer’s published protocol; off-protocol use voids both safety and efficacy claims.

Treatment protocol

20 minutes per session, 3× per week for the first 4 weeks, then maintenance 1–2× per week. Total time commitment over 3 years at maintenance: ~150 hours. This is the highest time commitment of any device in the home-RF/microcurrent/LED category — and the compliance gap is the editorial wrinkle.

3-Year Cost of Ownership

Component	Cost
NEWA Plus (wireless)	$479
NEWA Classic (corded)	$339
Conductive gel (~6 bottles/yr × 3 yrs)	~$540
3-year total — NEWA Plus + gel	~$1,019
3-year total — NEWA Classic + gel	~$879

Compare: NuFACE Trinity+ ($395 + ~$120/yr gel = ~$755 over 3 yrs), Foreo Bear 2 ($299, no recurring consumable = $299), CurrentBody Skin LED Mask ($395, no recurring consumable = $395).

NEWA’s hardware is mid-priced for the category, but the gel consumable adds $180/yr — about 50% more total than competitors over a 3-year window.

Regulatory Status

FDA De Novo Cleared (DEN150005). This is a regulatory pathway used for novel low-to-moderate-risk devices that don’t have a predicate device for a 510(k). De Novo clearance establishes the device as a new classification — and means the FDA reviewed both safety and efficacy data for the specific wrinkle-reduction indication.

Crucially, “De Novo cleared” is stronger than 510(k) cleared in the regulatory sense, because there was no predicate to claim equivalence to — FDA had to evaluate the device on its own evidence. This matters when comparing NEWA to competitors that ship under “FDA-registered” (an administrative listing, not a clearance) or “510(k) cleared for [unrelated indication], used off-label for wrinkles.”

You can verify the clearance directly on accessdata.fda.gov: search for DEN150005.

NEWA vs the Alternatives

vs NuFACE (microcurrent): Different mechanism. NuFACE uses low-current electrical stimulation; NEWA uses RF heat. Both have FDA clearances, both have published evidence. NuFACE has shorter sessions (5 min) and lower per-session commitment; NEWA has the only RF-specific wrinkle-reduction clearance.

vs Foreo Bear 2 (microcurrent + RF hybrid): Foreo’s RF is positioned as supplemental to microcurrent; the device’s primary clearance pathway is not for wrinkle reduction. NEWA’s regulatory position is cleaner if RF is what you want.

vs CurrentBody Skin LED Mask: Different mechanism (LED vs RF). LED has its own evidence base for skin texture and tone. They’re complementary rather than competing in a serious anti-aging stack.

Verdict: Recommended

NEWA earns the recommendation on the strength of its FDA De Novo clearance and published clinical evidence — both unique in the home-RF category. For buyers who specifically want RF wrinkle reduction at home, with the strongest regulatory and evidence backing available, this is the right answer.

The recommendation is conditional on protocol compliance: a 20-minute session three times a week is a real lifestyle commitment, and the published efficacy evidence assumes you’ll do it. Gel consumable cost adds ~$180/yr that competitors don’t carry.

If you can’t commit to 20-minute sessions three times a week, NEWA’s evidence base doesn’t apply to you — and a daily-habit microcurrent device (NuFACE) or LED mask (CurrentBody, Omnilux) is a better behavioral fit even with a different mechanism.

Changelog

• 2026-05-05: Initial review published based on FDA De Novo file (DEN150005) and manufacturer clinical data. Hands-on RF output and temperature-sensor testing pending.